• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由共同髓系祖细胞发育而来的CD8α阳性树突状细胞

Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.

作者信息

Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman E G, Weissman I L

机构信息

Department of Pathology, Stanford University, Stanford, CA 94305, USA.

出版信息

Science. 2000 Dec 15;290(5499):2152-4. doi: 10.1126/science.290.5499.2152.

DOI:10.1126/science.290.5499.2152
PMID:11118150
Abstract

Dendritic cells (DCs) are critical in both initiating adaptive immune responses and maintaining tolerance to self antigens. These apparently contradictory roles have been suggested to depend on different subsets of DCs that arise from either myeloid or lymphoid hematopoietic origins, respectively. Although DC expression of CD8alpha is attributed to a lymphoid origin, here we show that both CD8alpha+ and CD8alpha- DCs can arise from clonogenic common myeloid progenitors in both thymus and spleen. Thus, expression of CD8alpha is not indicative of a lymphoid origin, and phenotypic and functional differences among DC subsets are likely to reflect maturation status rather than ontogeny.

摘要

树突状细胞(DCs)在启动适应性免疫反应和维持对自身抗原的耐受性方面都起着关键作用。有人提出,这些明显相互矛盾的作用取决于分别源自髓系或淋巴系造血起源的不同DC亚群。尽管CD8α的DC表达归因于淋巴系起源,但我们在此表明,CD8α+和CD8α-DCs都可源自胸腺和脾脏中的克隆性共同髓系祖细胞。因此,CD8α的表达并不表明是淋巴系起源,DC亚群之间的表型和功能差异可能反映的是成熟状态而非个体发生。

相似文献

1
Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.由共同髓系祖细胞发育而来的CD8α阳性树突状细胞
Science. 2000 Dec 15;290(5499):2152-4. doi: 10.1126/science.290.5499.2152.
2
Dendritic cell potentials of early lymphoid and myeloid progenitors.早期淋巴细胞和髓细胞祖细胞的树突状细胞潜能
Blood. 2001 Jun 1;97(11):3333-41. doi: 10.1182/blood.v97.11.3333.
3
Dendritic cell development from common myeloid progenitors.从常见髓系祖细胞发育而来的树突状细胞。
Ann N Y Acad Sci. 2001 Jun;938:167-73; discussion 173-4. doi: 10.1111/j.1749-6632.2001.tb03586.x.
4
Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors.重新审视淋巴样与髓样树突状细胞谱系的概念:CD8α(-)和CD8α(+)树突状细胞均由CD4(low)淋巴样定向前体细胞产生。
Blood. 2000 Oct 1;96(7):2511-9.
5
Identification of CD8alpha+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8alpha+ dendritic cells.鉴定脾脏中CD8α⁺CD11c⁻谱系表型阴性细胞为CD8α⁺树突状细胞的定向前体细胞。
Blood. 2002 Jul 15;100(2):569-77. doi: 10.1182/blood.v100.2.569.
6
Murine dendritic cells derived from myeloid progenitors of the thymus are unable to produce bioactive IL-12p70.源自胸腺髓样祖细胞的小鼠树突状细胞无法产生具有生物活性的IL-12p70。
J Immunol. 2001 Apr 15;166(8):5008-17. doi: 10.4049/jimmunol.166.8.5008.
7
Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells.CD11b+、CD8α+和双阴性派尔集合淋巴结树突状细胞的独特功能。
J Immunol. 2001 Apr 15;166(8):4884-90. doi: 10.4049/jimmunol.166.8.4884.
8
The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells.CD8α(+) 胸腺树突状细胞的最早的胸腺内前体对应于髓样型双阴性 1c 细胞。
Eur J Immunol. 2011 Aug;41(8):2165-75. doi: 10.1002/eji.201141728. Epub 2011 Jul 4.
9
Development of thymic and splenic dendritic cell populations from different hemopoietic precursors.不同造血前体来源的胸腺和脾脏树突状细胞群体的发育。
Blood. 2001 Dec 1;98(12):3376-82. doi: 10.1182/blood.v98.12.3376.
10
Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice.自身免疫易感性非肥胖糖尿病小鼠中髓系祖细胞来源的树突状细胞生成增加。
J Immunol. 2002 May 15;168(10):5032-41. doi: 10.4049/jimmunol.168.10.5032.

引用本文的文献

1
A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains.源自移植到NOD衍生小鼠品系中的人类造血干细胞的淋巴细胞和髓细胞的比较。
Microorganisms. 2023 Jun 10;11(6):1548. doi: 10.3390/microorganisms11061548.
2
Unboxing dendritic cells: Tales of multi-faceted biology and function.胞突细胞的剖析:多面生物学和功能的故事。
Immunology. 2021 Nov;164(3):433-449. doi: 10.1111/imm.13394. Epub 2021 Aug 8.
3
Negative Regulation of the Differentiation of Flk2 CD34 LSK Hematopoietic Stem Cells by EKLF/KLF1.
EKLF/KLF1 对 Flk2+CD34+LSK 造血干/祖细胞分化的负调控
Int J Mol Sci. 2020 Nov 10;21(22):8448. doi: 10.3390/ijms21228448.
4
Functional Human CD141+ Dendritic Cells in Human Immune System Mice.功能性人 CD141+ 树突状细胞在人免疫系统小鼠中。
J Infect Dis. 2020 Jan 2;221(2):201-213. doi: 10.1093/infdis/jiz432.
5
Shared Transcriptional Control of Innate Lymphoid Cell and Dendritic Cell Development.先天淋巴细胞和树突状细胞发育的共调控。
Annu Rev Cell Dev Biol. 2019 Oct 6;35:381-406. doi: 10.1146/annurev-cellbio-100818-125403. Epub 2019 Jul 5.
6
Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy.使用一种新型细胞分选策略从鼠骨髓中大量生成髓系祖细胞和树突状细胞前体
J Vis Exp. 2018 Aug 10(138):57365. doi: 10.3791/57365.
7
Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes.与外周血来源的髓样树突状细胞相比,人骨髓来源的髓样树突状细胞呈现出不成熟的转录和功能特征,且与Slan + 非经典单核细胞不同。
Front Immunol. 2018 Jul 16;9:1619. doi: 10.3389/fimmu.2018.01619. eCollection 2018.
8
Analysis of the developmental stages, kinetics, and phenotypes exhibited by myeloid cells driven by GM-CSF in vitro.体外分析由粒细胞-巨噬细胞集落刺激因子(GM-CSF)驱动的髓系细胞所呈现的发育阶段、动力学及表型。
PLoS One. 2017 Jul 27;12(7):e0181985. doi: 10.1371/journal.pone.0181985. eCollection 2017.
9
Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors.人类早期造血祖细胞中的树突状细胞谱系潜能
Cell Rep. 2017 Jul 18;20(3):529-537. doi: 10.1016/j.celrep.2017.06.075.
10
MiR-34a promotes DCs development and inhibits their function on T cell activation by targeting WNT1.微小RNA-34a通过靶向WNT1促进树突状细胞的发育并抑制其对T细胞激活的功能。
Oncotarget. 2017 Mar 7;8(10):17191-17201. doi: 10.18632/oncotarget.15228.